首頁 > 市場調查報告書 > 醫療設備

體外診斷泌尿科

市場調查報告書

商品編碼

1496875

全球尿液分析市場 - 2024-2031

Global Urinalysis Market - 2024-2031

出版日期: 2024年06月18日 | 出版商:

DataM Intelligence | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

司機

尿路感染和泌尿系統疾病的盛行率上升

全球尿液分析市場的需求是由多種因素所驅動的。關鍵因素之一是泌尿道感染和泌尿系統疾病的盛行率上升。泌尿道感染（UTI）是全世界最常見的感染之一。

根據 2023 年 10 月的 BMC 傳染病出版物，泌尿道感染 (UTI) 是第二常見傳染病，每年影響全球超過 1.5 億人。泌尿道致病性大腸桿菌 (UPEC) 是泌尿道感染的主要原因，可能以與抗菌素抗藥性 (AMR) 相關的生物膜形式出現。

尿液顆粒分析和尿液沉渣測試是用於診斷腎臟和泌尿道疾病的重要測試。此測試透過對尿液中形成的顆粒（例如紅血球、白血球和細菌）進行分類和測量來進行。

此外，該行業的主要參與者技術創新（例如尿路感染治療中的人工智慧）有助於推動該市場的成長。例如，2024 年 1 月，碩騰公司 (Zoetis Inc.) 宣布擴展其多應用診斷平台 Vetscan Imagyst，將人工智慧尿液沉渣分析納入其中。新的應用程式將能夠對新鮮尿液進行準確的臨床沉積物分析，使臨床醫生能夠快速做出治療決策。

此外，2023 年 1 月，Starling Medical 的新型尿液檢測設備可將您的馬桶變成健康追蹤器。使用一些人工智慧和光譜感測器，導管將追蹤患者膀胱中的尿液，以檢測泌尿道感染，這可能導致住院和敗血症。

限制

尿液分析測試和設備的高成本、嚴格的法規核准流程、尿液分析測試和解釋的複雜性、醫療保健專業人員的意識有限和缺乏教育以及有限的報銷政策等因素預計將阻礙市場。

有關此報告的更多詳細資訊 - 索取樣本

A urinalysis involves checking the appearance, concentration, and content of urine. For example, a urinary tract infection can make urine look cloudy instead of clear. Increased levels of protein in urine can be a sign of kidney disease. It plays a crucial role in the early detection and management of diseases, making it an essential diagnostic tool for healthcare professionals worldwide.

The major key factors driving the market are the rising prevalence of urinary tract infections & urological disorders, the growing geriatric population & the burden of chronic kidney diseases, the rising preference for point-of-care testing, and technological advancements in the healthcare industry.

Market Dynamics

Drivers

Rising Prevalence of Urinary Tract Infections & Urological Disorders

The demand for the global urinalysis market is driven by multiple factors. One of the key factors is the rising prevalence of UTI & urological disorders. Urinary tract infections (UTIs) are one of the most common infections worldwide.

As per BMC Infectious Disease publication in October 2023, urinary tract infection (UTI) is the second most common infectious disease affecting more than 150 million people globally annually. Uropathogenic E. coli (UPEC), the predominant cause of UTI, can occur as a biofilm-associated with antimicrobial resistance (AMR).

Urine particle analysis & urine sediment testing is an important test used to diagnose renal and urinary tract disorders. This test is conducted by classifying and measuring particles formed in urine, such as red blood cells, white blood cells, and bacteria.

Moreover, key players in the industry technological innovations such as AI in UTI treatment help to drive this market growth. For instance, in January 2024, Zoetis Inc., announced the expansion of its multi-application diagnostics platform, Vetscan Imagyst, to include AI Urine Sediment analysis. The new application will enable accurate, in-clinic sediment analysis of fresh urine, allowing clinicians to make treatment decisions quickly.

Also, in January 2023, Starling Medical's new urine-testing device turns your toilet into a health tracker. Using some AI and spectroscopy sensors, the catheter would track the urine still in a patient's bladder to detect urinary tract infections, which can lead to hospitalizations and sepsis.

Restraints

Factors such as the high cost of urinalysis tests & equipment, stringent regulatory approval process, complexity of urinalysis testing & interpretation, limited awareness & lack of education among healthcare professionals, and limited reimbursement policies are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global urinalysis market is segmented based on product, test type, application, end-user, and region.

The instruments segment accounted for approximately 43.3% of the global urinalysis market share

The instruments segment is expected to hold the largest market share over the forecast period. A urine analyzer is a device used in the clinical setting to perform automatic urine testing. The units can detect and quantify several analytes including bilirubin, protein, glucose, and red blood cells. Many models contain urine strip readers, a type of reflectance photometer that can process several hundred strips per hour.

In addition, major players in the industry launching new analyzers for UTI infections would propel this segment's growth. For instance, in December 2023, Siemens Healthineers now offer high-resolution, digital urine microscopy with its compact Atellica UAS 60 analyzer.

This is a compact solution for urine sediment analysis, that can automate a lab's urinalysis workflow with full field-of-view digital imaging that closely replicates manual microscopy. Laboratory professionals can more rapidly and accurately review and report urine sediment results by replacing routine manual microscopy with an automated, digital alternative.

Similarly, in April 2023, Sysmex Europe launched the UF-1500 Fully Automated Urine Particle Analyser (UF-1500), a new product for use in particle analysis. The UF-1500 inherits the high levels of functionality and usability of the UF-5000 Fully Automated Urine Particle Analyser (UF-5000), our flagship model in urine particle analysis while achieving a downsizing of the former model.

Geographical Analysis

North America accounted for approximately 45.6% of the global urinalysis market share

North America region is expected to hold the largest market share over the forecast period owing to the rising prevalence of UTI cases helping to drive this market growth. As per Medscape U.S. statistics in February 2024, UTIs in women are very common in the U.S., approximately 25-40% of women in the United States aged 20-40 years have had a UTI.

Furthermore, in this region, a major key player's presence, well-developed healthcare infrastructure, and innovative developments, urine test approvals would propel this market growth. For instance, in January 2023, Withings announced U-Scan, the world's first hands-free connected home urine lab.

Sophisticated urine analysis allows users to monitor metabolic insights and empowers women to manage monthly cycles ability of U-Scan to perform daily urine analysis from the home will allow Withings to take its mission to help consumers fully utilize urine data to an entirely new level.

Similarly, in October 2023, the Food and Drug Administration cleared for marketing the first over-the-counter test to detect fentanyl in urine.

Market Segmentation

By Product

Instruments
- Semi-Automated Urine Analyzers
- Automated Urine Analyzers
Consumables
- Disposables
- Dipsticks
- Reagents & Kits
- Others

By Test Type

Pregnancy & Fertility Tests
Sediment Urinalysis
Biochemical Urinalysis
- Point-Of-Care Tests
- Laboratory Tests

By Application

Urinary Tract Infections
Diabetes
Kidney Diseases
Liver Diseases
Others

By End-User

Hospitals
Home Care Settings
Diagnostic Laboratories
Research Laboratories & Academic Institutes
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the urinalysis market include Abbott, Siemens Healthcare Private Limited, BD, Thermo Fisher Scientific, 77 Elektronika Kft, F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Sysmex, ACON Laboratories Inc, and Analyticon Biotechnologies GmbH among others.

Key Developments

In January 2024, Una Health Ltd was delighted to unveil the new, enhanced model of the Urisys 1100 Urine Analyser from Roche Diagnostics. Boasting a sleek and compact design, the Urisys 1100 stands out as one of the smallest and lightest devices in its class, designed for fast, safe, and accurate urinalysis.
In August 2023, Signify Health launches in-home testing for chronic kidney disease. It is expanding its services with the addition of a new in-home testing option for chronic kidney disease.
In February 2023, Sysmex introduced automated urinalysis testing solutions that revolutionized workflow at Medlab Middle East 2023. It presents its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, hemostasis, and flow cytometry.
In January 2023, Vivoo announced the launch of the world's first smart toilet clip-on device that will help in the early detection of health conditions. The toilet is a game-changer for healthcare and caring professionals, enabling users to perform urine testing and receive personalized wellness, health, and nutritional recommendations without the mess.

Why Purchase the Report?

To visualize the global urinalysis market segmentation based on product, test type, application, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global urinalysis market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The global urinalysis market report would provide approximately 70 tables, 72 figures, and 182 Pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Test Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Urinary Tract Infections & Urological Disorders
  - 4.1.1.2. Growing Geriatric Population & Burden of Chronic Kidney Disease
  - 4.1.1.3. Rising Preference for Point of Care Testing
  - 4.1.1.4. Technological Advancements in the Healthcare Industry
- 4.1.2. Restraints
  - 4.1.2.1. The High Cost of Urinalysis Tests & Equipment
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers' Strategic Initiatives
6.6. Conclusion

7. By Product

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 7.1.2. Market Attractiveness Index, By Product
7.2. Instruments*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Semi-Automated Urine Analyzers
7.4. Automated Urine Analyzers
7.5. Consumables
7.6. Disposables
7.7. Dipsticks
7.8. Reagents & Kits
7.9. Others

8. By Test Type

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 8.1.2. Market Attractiveness Index, By Test Type
8.2. Pregnancy & Fertility Tests*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Sediment Urinalysis
8.4. Biochemical Urinalysis
8.5. Point-Of-Care Tests
8.6. Laboratory Tests

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Urinary Tract Infections *
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diabetes
9.4. Kidney Diseases
9.5. Liver Diseases
9.6. Others

10. By End-User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.1.2. Market Attractiveness Index, By End-User
10.2. Hospitals *
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Home Care Settings
10.4. Diagnostic Laboratories
10.5. Research Laboratories & Academic Institutes
10.6. Others

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. South Korea
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. Abbott *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio & Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Siemens Healthcare Private Limited
13.3. BD
13.4. Thermo Fisher Scientific
13.5. 77 Elektronika Kft
13.6. F. Hoffmann-La Roche Ltd
13.7. Beckman Coulter Inc
13.8. Sysmex
13.9. ACON Laboratories Inc
13.10. Analyticon Biotechnologies GmbH

LIST NOT EXHAUSTIVE